STOCK TITAN
  1. Home
  2. Sec-filings
  3. RCKT
  4. [144] ROCKET PHARMACEUTICALS, INC. SEC Filing

Rocket Pharma (NASDAQ: RCKT) officer to resell $2.1K in vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ROCKET PHARMACEUTICALS, INC. (RCKT) is the issuer for a planned resale of common stock under Rule 144 for the account of officer Martin Wilson. A notice was filed for the potential sale of 631 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of $2,133.66 as of 08/18/2026 on NASDAQ. The shares derive from restricted stock vesting on 08/14/2026 and are characterized as compensation. In the prior three months, Wilson reported sales of 662 shares for $1,995.53 on 05/19/2026 and 3,493 shares for $11,810.18 on 08/13/2026. The filer notes that the sale includes shares to cover a tax obligation from the settlement of a vested equity award.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 631 shares Common stock under Rule 144 for Martin Wilson
Aggregate market value of planned sale $2,133.66 Value for 631 shares as of 08/18/2026
Past sale on 05/19/2026 662 shares for $1,995.53 Common stock sold by Martin Wilson in prior 3 months
Past sale on 08/13/2026 3,493 shares for $11,810.18 Common stock sold by Martin Wilson in prior 3 months
Vesting date of restricted stock 08/14/2026 Source of shares noted as Restricted Stock Vesting
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Common | 08/14/2026 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
attorney-in-fact regulatory
"as attorney-in-fact for Martin Wilson"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
aggregate market value financial
"631 | 2133.66 | 109774597 | 08/18/2026 | NASDAQ"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

What does the Form 144 filing mean for ROCKET PHARMACEUTICALS, INC. (RCKT)?
The Form 144 reports a planned resale of 631 RCKT common shares by officer Martin Wilson under Rule 144. It is a disclosure of a potential sale of restricted shares, not an offering by Rocket Pharmaceuticals itself.

How many RCKT shares are planned to be sold under this Rule 144 notice?
The notice covers a potential sale of 631 common shares of RCKT. These shares are to be sold through Fidelity Brokerage Services LLC and are tied to restricted stock vesting dated 08/14/2026.

What is the reported market value of the RCKT shares covered by this Form 144?
The 631 RCKT shares covered by the notice have an aggregate market value of $2,133.66 as of 08/18/2026. This figure is disclosed in connection with the planned sale on NASDAQ.

What RCKT share sales has Martin Wilson reported in the past three months?
Martin Wilson reported selling 662 RCKT shares for $1,995.53 on 05/19/2026 and 3,493 shares for $11,810.18 on 08/13/2026. These prior transactions are disclosed as required for aggregation under Rule 144.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR